TEST BANK px
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
px px px px px px px
Author: Teri Moser Woo and Wendy L. Wright
px px px px px px px
, TABLE OF CONTENTpx px
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
px px px px px px px px px px
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
px px px px px px px
Chapter 3. Rational Drug Selection..................................................................................................................... 11
px px px px
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
px px px px px px px
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
px px px px
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
px px px px px
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
px px px px
Chapter 8. Herbal Therapies ................................................................................................................................ 28
px px px
Chapter 9. Cannabis ............................................................................................................................................ 31
px px
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
px px
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
px px px px px px px
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
px px px px px px px
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
px px px px px px px px
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
px px px px px px
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
px px px px px px
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
px px px px px px px px px
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
px px px px px px px
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
px px px px px px
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
px px px px px px px px px px px
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
px px px px px px px px px px px
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
px px px px px px
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
px px px px px px px
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
px px px px px px
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
px px px px px px px
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
px px px px px px px px px px
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
px px px px px px px
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
px px px px px px px px px
Chapter 28. Anemia .......................................................................................................................................... 113
px px
Chapter 29. Anxiety and Depression................................................................................................................. 116
px px px px
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
px px px px
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
px px px px
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
px px px px px
Chapter 33. Contraception ................................................................................................................................. 127
px px
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
px px px px px
Chapter 35. Dermatological Conditions ............................................................................................................ 134
px px px
Chapter 36. Diabetes Management ................................................................................................................... 138
px px px
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
px px px px px px px
Chapter 38. Headaches ...................................................................................................................................... 149
px px
Chapter 39. Heart Failure .................................................................................................................................. 153
px px px
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
px px px px px px px
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
px px px px
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
px px
Chapter 43. Hypertension .................................................................................................................................. 169
px px
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
px px px px
Chapter 45. Obesity ........................................................................................................................................... 177
px px
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
px px px px px px px
Chapter 47. Pneumonia ..................................................................................................................................... 185
px px
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
px px px px px px
Chapter 49. Substance Use Disorders ............................................................................................................... 190
px px px px
Chapter 50. Tuberculosis ................................................................................................................................... 195
px px
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
px px px px px px px px px px px px
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
px px px px
Chapter 53. Women as Patients......................................................................................................................... 203
px px px px
Chapter 54. Men as Patients .............................................................................................................................. 207
px px px px
Chapter 55. Pediatric Patients ........................................................................................................................... 209
px px px
Chapter 57. Geriatric Patients ........................................................................................................................... 213
px px px
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e px px px px Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
px px px px px px px px px px
MULTIPLE CHOICE px
1. Nurse practitioner prescriptive authority is regulated by:
px px px px px px
A. The National Council of State Boards of Nursing
px px px px px px px
B. The U.S. Drug Enforcement Administration
px px px px
C. The State Board of Nursing for each state
px px px px px px px
D. The State Board of Pharmacy
px px px px
ANS: C p x PTS: p x p x 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
px px px px px px px px px px px px px px
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
px px px px px px px px px px px px
both in their basic nursing program and in their APRN program.
px px px px px px px px px px
B. Nurses care for the patient from a holistic approach and include the patient in
px px px px px px px px px px px px px px
decision-making regarding their care. px px px
C. APRNs are less likely to prescribe narcotics and other controlled substances.
px px px px px px px px px px
D. APRNs are able to prescribe independently in all states, whereas a physician’s
px px px px px px px px px px px px
assistant needs to have a physician supervising their practice.
px px px px px px px px
ANS: B p x PTS: p x p x 1
3. Clinical judgment in prescribing includes:
px px px px
A. Factoring in the cost to the patient of the medication prescribed
px px px px px px px px px px
B. Always prescribing the newest medication available for the disease process
px px px px px px px px px
C. Handing out drug samples to poor patients px px px px px px
D. Prescribing all generic medications to cut costs px px px px px px
ANS: A p x PTS: p x p x 1
4. The process for choosing an effective drug for a disorder includes:
px px px px px px px px px px
A. Asking the patient what drug they think would work best for them
px px px px px px px px px px px
B. Consulting nationally recognized guidelines for disease management
px px px px px px
C. Prescribing medications that are available as samples before writing a prescription
px px px px px px px px px px
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
px px px px px px px
ANS: B p x PTS: p x p x 1
5. Nonintentional nonadherence of drug therapy may occur due to: px px px px px px px px
A. Belief that medication does not work
px px px px px
B. Adverse drug reactions px px
C. Chronic conditions that require daily therapypx px px px px
D. Forgetfulness or distraction px px
ANS: D p x PTS: p x p x 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
px px px px px px px
Author: Teri Moser Woo and Wendy L. Wright
px px px px px px px
, TABLE OF CONTENTpx px
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
px px px px px px px px px px
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
px px px px px px px
Chapter 3. Rational Drug Selection..................................................................................................................... 11
px px px px
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
px px px px px px px
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
px px px px
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
px px px px px
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
px px px px
Chapter 8. Herbal Therapies ................................................................................................................................ 28
px px px
Chapter 9. Cannabis ............................................................................................................................................ 31
px px
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
px px
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
px px px px px px px
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
px px px px px px px
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
px px px px px px px px
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
px px px px px px
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
px px px px px px
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
px px px px px px px px px
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
px px px px px px px
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
px px px px px px
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
px px px px px px px px px px px
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
px px px px px px px px px px px
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
px px px px px px
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
px px px px px px px
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
px px px px px px
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
px px px px px px px
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
px px px px px px px px px px
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
px px px px px px px
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
px px px px px px px px px
Chapter 28. Anemia .......................................................................................................................................... 113
px px
Chapter 29. Anxiety and Depression................................................................................................................. 116
px px px px
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
px px px px
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
px px px px
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
px px px px px
Chapter 33. Contraception ................................................................................................................................. 127
px px
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
px px px px px
Chapter 35. Dermatological Conditions ............................................................................................................ 134
px px px
Chapter 36. Diabetes Management ................................................................................................................... 138
px px px
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
px px px px px px px
Chapter 38. Headaches ...................................................................................................................................... 149
px px
Chapter 39. Heart Failure .................................................................................................................................. 153
px px px
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
px px px px px px px
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
px px px px
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
px px
Chapter 43. Hypertension .................................................................................................................................. 169
px px
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
px px px px
Chapter 45. Obesity ........................................................................................................................................... 177
px px
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
px px px px px px px
Chapter 47. Pneumonia ..................................................................................................................................... 185
px px
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
px px px px px px
Chapter 49. Substance Use Disorders ............................................................................................................... 190
px px px px
Chapter 50. Tuberculosis ................................................................................................................................... 195
px px
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
px px px px px px px px px px px px
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
px px px px
Chapter 53. Women as Patients......................................................................................................................... 203
px px px px
Chapter 54. Men as Patients .............................................................................................................................. 207
px px px px
Chapter 55. Pediatric Patients ........................................................................................................................... 209
px px px
Chapter 57. Geriatric Patients ........................................................................................................................... 213
px px px
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e px px px px Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
px px px px px px px px px px
MULTIPLE CHOICE px
1. Nurse practitioner prescriptive authority is regulated by:
px px px px px px
A. The National Council of State Boards of Nursing
px px px px px px px
B. The U.S. Drug Enforcement Administration
px px px px
C. The State Board of Nursing for each state
px px px px px px px
D. The State Board of Pharmacy
px px px px
ANS: C p x PTS: p x p x 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
px px px px px px px px px px px px px px
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
px px px px px px px px px px px px
both in their basic nursing program and in their APRN program.
px px px px px px px px px px
B. Nurses care for the patient from a holistic approach and include the patient in
px px px px px px px px px px px px px px
decision-making regarding their care. px px px
C. APRNs are less likely to prescribe narcotics and other controlled substances.
px px px px px px px px px px
D. APRNs are able to prescribe independently in all states, whereas a physician’s
px px px px px px px px px px px px
assistant needs to have a physician supervising their practice.
px px px px px px px px
ANS: B p x PTS: p x p x 1
3. Clinical judgment in prescribing includes:
px px px px
A. Factoring in the cost to the patient of the medication prescribed
px px px px px px px px px px
B. Always prescribing the newest medication available for the disease process
px px px px px px px px px
C. Handing out drug samples to poor patients px px px px px px
D. Prescribing all generic medications to cut costs px px px px px px
ANS: A p x PTS: p x p x 1
4. The process for choosing an effective drug for a disorder includes:
px px px px px px px px px px
A. Asking the patient what drug they think would work best for them
px px px px px px px px px px px
B. Consulting nationally recognized guidelines for disease management
px px px px px px
C. Prescribing medications that are available as samples before writing a prescription
px px px px px px px px px px
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
px px px px px px px
ANS: B p x PTS: p x p x 1
5. Nonintentional nonadherence of drug therapy may occur due to: px px px px px px px px
A. Belief that medication does not work
px px px px px
B. Adverse drug reactions px px
C. Chronic conditions that require daily therapypx px px px px
D. Forgetfulness or distraction px px
ANS: D p x PTS: p x p x 1
